SLC5A7 and hereditary pheochromocytoma-paraganglioma: In contrast, Li et al. [35] showed that SLC5A7 expression was downregulated in several cancer types, including thyroid cancer (THCA) and pheochromocytoma and paraganglioma (PCPG).